Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Interventional Study to Evaluate the Safety and Tolerability of Mirabegron and Montelukast in Patients With Liver Cirrhosis

NCT07533565 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT07533565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07533565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Interventional Study to Evaluate the Safety and Tolerability of Mirabegron and Montelukast in Patients With Liver Cirrhosis
Lead sponsor
Kafrelsheikh University
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2024
Completion date
October 1, 2025
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, cirrhosis